Home › Drug developer Virobay lines up $50M IPO
 

Keywords :   


Drug developer Virobay lines up $50M IPO

2014-09-11 08:15:58| Biotech - Topix.net

Drug developer Virobay Inc. hopes to raise $50 million in an initial public offering for a critical year of clinical trials, according to the Menlo Park company's U.S. Securities and Exchange Commission filing Wednesday. The offering is the latest in a line of Bay Area biotech IPOs, including ones that could hit the market yet this month.

Tags: lines drug developer ipo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 12
More »